Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Thoracic Cancer|March 29, 2019
Favorable predictors for survival in advanced ALK-positive non-small cell lung cancer patients beyond crizotinib resistanceHaiyan Xu, Guangjian Yang, Lu Yang, et al.
Frontiers in Pharmacology|October 3, 2022
EGFR uncommon alterations in advanced non-small cell lung cancer and structural insights into sensitivity to diverse tyrosine kinase inhibitorsHaiyan Xu, Guangjian Yang, Runze Liu, et al.
Frontiers in Oncology|May 16, 2020
Clinical Characteristics and Treatment Outcomes of 65 Patients With BRAF-Mutated Non-small Cell Lung CancerYuxin Mu, Ke Yang, Xuezhi Hao, et al.
Translational Lung Cancer Research|February 9, 2026
Efficacy and safety of lorlatinib in first-line and subsequent-line treatments for patients with ALK-positive non-small cell lung cancer: a single-center real-world study in ChinaLige Wu, Jiayu Liu, Zihua Zou, et al.
Future Oncology (London, England)|November 1, 2023
Immunotherapy as a later-line option for HER2-altered advanced non-small-cell lung cancer: taxane might be a favorable partnerYaning Yang, Guangjian Yang, Weihua Li, et al.
The Oncologist|April 7, 2020
A Prospective Study of Apatinib in Patients with Extensive-Stage Small Cell Lung Cancer After Failure of Two or More Lines of ChemotherapyYutao Liu, Xingsheng Hu, Jun Jiang, et al.
Cancer|August 4, 2023
Low TP53 variant allele frequency as a biomarker for anti-programmed death (ligand) 1 monotherapy in lung adenocarcinomaShouzheng Wang, Tongji Xie, Yan Li, et al.
Translational Cancer Research|February 4, 2022
The clinical significance of RET gene fusion among Chinese patients with lung cancerPuyuan Xing, Nong Yang, Xue Hu, et al.
Chinese Medical Journal|August 19, 2014
Prognosis of R1-resection at the bronchial stump in patients with non-small cell lung cancerJima Lyu, Xuezhi Hao, Zhouguang Hui, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|May 24, 2014
[Efficacy of gefitinib for young patients with unknown EGFR gene mutation in advanced lung adenocarcinoma]Yutao Liu, Yuankai Shi, Xingsheng Hu, et al.
Pageof 11